Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5043452_CN43452_0